- Home
- VRDN vs EIG Comparison
VRDN vs EIG Comparison
Compare VRDN & EIG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRDN
- EIG
- Stock Information
- Founded
- VRDN 2006
- EIG 2000
- Country
- VRDN United States
- EIG United States
- Employees
- VRDN N/A
- EIG N/A
- Industry
- VRDN Medical Specialities
- EIG Property-Casualty Insurers
- Sector
- VRDN Health Care
- EIG Finance
- Exchange
- VRDN Nasdaq
- EIG Nasdaq
- Market Cap
- VRDN 1.5B
- EIG 1.3B
- IPO Year
- VRDN N/A
- EIG 2007
- Fundamental
- Price
- VRDN $20.14
- EIG $52.96
- Analyst Decision
- VRDN Strong Buy
- EIG Strong Buy
- Analyst Count
- VRDN 10
- EIG 1
- Target Price
- VRDN $37.25
- EIG $58.00
- AVG Volume (30 Days)
- VRDN 1.1M
- EIG 116.9K
- Earning Date
- VRDN 11-12-2024
- EIG 10-30-2024
- Dividend Yield
- VRDN N/A
- EIG 2.27%
- EPS Growth
- VRDN N/A
- EIG 20.58
- EPS
- VRDN N/A
- EIG 5.34
- Revenue
- VRDN $302,000.00
- EIG $889,800,000.00
- Revenue This Year
- VRDN N/A
- EIG N/A
- Revenue Next Year
- VRDN N/A
- EIG $1.03
- P/E Ratio
- VRDN N/A
- EIG $9.90
- Revenue Growth
- VRDN N/A
- EIG 5.05
- 52 Week Low
- VRDN $11.40
- EIG $37.40
- 52 Week High
- VRDN $27.20
- EIG $54.44
- Technical
- Relative Strength Index (RSI)
- VRDN 36.38
- EIG 65.03
- Support Level
- VRDN $22.40
- EIG $47.64
- Resistance Level
- VRDN $27.20
- EIG $54.44
- Average True Range (ATR)
- VRDN 1.36
- EIG 1.05
- MACD
- VRDN -0.41
- EIG 0.34
- Stochastic Oscillator
- VRDN 6.37
- EIG 79.01
About VRDN Viridian Therapeutics Inc.
Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate VRDN-001 is an insulin-like growth factor-1 receptor (IGF-1R) monoclonal antibody (mAb) being developed for the potential treatment for patients with thyroid eye disease.
About EIG Employers Holdings Inc
Employers Holdings Inc provides workers' compensation insurance, to small businesses in low- to medium-hazard industries. Its customers are employers, and the insurance premiums that those employers pay to account for company revenue. Substantially all of the remaining revenue is generated through investments. The company operates exclusively in the United States, and it generates more than half of its business in California. By industry, the company has exposure to restaurants, which account for roughly a fourth of the total premiums the company earns. It operates as a single reportable segment, Insurance Operations, through itswholly owned subsidiaries.